Bio Port Korea바이오포트
188040 · KOSDAQ · ₩188040 · 바이오포트
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩6,861
vs the current price (₩5,190)
- Enterprise value
- ₩28B
- Equity value
- ₩32B
- WACC
- 7.3%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Bear / Base / Bull
- Bear
- ₩2,490
- −52.0%
- Base
- ₩6,861
- +32.2%
- Bull
- ₩14,899
- +187.1%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (3.8%).
Revenue growth
- -3.4%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (-3.4% a year, annual reports), fading to 3% by year 5.
- -1.8%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (-3.4% a year, annual reports), fading to 3% by year 5.
- -0.2%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (-3.4% a year, annual reports), fading to 3% by year 5.
- 1.4%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (-3.4% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (-3.4% a year, annual reports), fading to 3% by year 5.
Business
- 3.8%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 2 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 3.2%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 4%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 2 annual reports (cash flow statements; equipment and intangibles).
- 15.9%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 2 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.01%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-30.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 76 weeks of weekly returns against KOSPI (official index); raw beta 0.04, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.51%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩78B
- Net debt (borrowings and leases − cash and deposits)
- −₩3.9B
- Shares
- 4,679,308
- Share price
- ₩5,190
- Market cap
- ₩24B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|
| Revenue | ₩73B | ₩71B | ₩75B | ₩74B | ₩74B | ₩75B | ₩77B |
| Growth | — | −3.4% | −3.4% | −1.8% | −0.2% | 1.4% | 3.0% |
| EBIT | ₩5.2B | ₩830M | ₩2.9B | ₩2.8B | ₩2.8B | ₩2.8B | ₩2.9B |
| EBIT margin | 7.1% | 1.2% | 3.8% | 3.8% | 3.8% | 3.8% | 3.8% |
| After-tax EBIT | ₩3.8B | ₩602M | ₩2.1B | ₩2B | ₩2B | ₩2.1B | ₩2.1B |
| + Depreciation | — | — | ₩2.4B | ₩2.4B | ₩2.4B | ₩2.4B | ₩2.5B |
| − Capital spending | ₩3.6B | ₩2.2B | ₩3B | ₩3B | ₩3B | ₩3B | ₩3.1B |
| − Working capital | — | −₩1.3B | −₩422M | −₩216M | −₩24M | ₩164M | ₩357M |
| Free cash flow | — | — | ₩1.9B | ₩1.7B | ₩1.5B | ₩1.3B | ₩1.2B |
| Discount factor | — | — | 0.932 | 0.868 | 0.809 | 0.754 | 0.703 |
| Present value | — | — | ₩1.8B | ₩1.4B | ₩1.2B | ₩980M | ₩808M |
Terminal value ₩31B, worth ₩22B today: 78% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | ₩7,438 | ₩7,810 | ₩8,265 | ₩8,838 | ₩9,581 |
| 6.8% | ₩6,858 | ₩7,145 | ₩7,490 | ₩7,912 | ₩8,444 |
| 7.3% | ₩6,370 | ₩6,595 | ₩6,861 | ₩7,180 | ₩7,571 |
| 7.8% | ₩5,954 | ₩6,133 | ₩6,340 | ₩6,585 | ₩6,880 |
| 8.3% | ₩5,596 | ₩5,739 | ₩5,903 | ₩6,093 | ₩6,319 |
Now (TTM)
- Market cap
- ₩24B
- Enterprise value
- ₩20B
- P/E
- 8.2×
- P/B
- 0.6×
- P/S
- 0.3×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | |
|---|---|
| Price | ₩8,050 |
| Market cap | ₩38B |
| P/E | — |
| P/B | 0.9× |
| P/S | 0.5× |
| EV/EBITDA | — |
| Dividend yield | 0.0% |
Loading data for this company — check back soon
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Bio Port Korea | 8.2× | 0.6× | 0.3× | — | 0.0% |
| Samyang Foods | 17.6× | 5.6× | 3.1× | — | 0.4% |
| Orion | 10.6× | 1.1× | 1.2× | 5.3× | 3.1% |
| CJ Cheiljedang | — | 0.3× | 0.1× | — | 3.5% |
| Nongshim | 12.0× | 0.8× | 0.6× | — | 1.5% |
| Otoki | 17.3× | 0.6× | 0.3× | — | 2.9% |
| Hite Jinro | 23.2× | 0.9× | 0.4× | 6.4× | 4.5% |
| Similar companies (median) | 17.3× | 0.9× | 0.5× | 5.8× | 3.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Bio Port Korea / 바이오포트 / 188040 / KRX:188040
Source: KRX statistical information